Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, September 3, 2019
[ Tue, Sep 03rd 2019
] - WOPRAI
[ Tue, Sep 03rd 2019
] - WOPRAI
[ Tue, Sep 03rd 2019
] - WOPRAI
[ Tue, Sep 03rd 2019
] - WOPRAI
[ Tue, Sep 03rd 2019
] - WOPRAI
Fri, August 30, 2019
[ Fri, Aug 30th 2019
] - WOPRAI
[ Fri, Aug 30th 2019
] - WOPRAI
[ Fri, Aug 30th 2019
] - WOPRAI
[ Fri, Aug 30th 2019
] - WOPRAI
[ Fri, Aug 30th 2019
] - WOPRAI
[ Fri, Aug 30th 2019
] - WOPRAI
[ Fri, Aug 30th 2019
] - WOPRAI
[ Fri, Aug 30th 2019
] - WOPRAI
[ Fri, Aug 30th 2019
] - WOPRAI
[ Fri, Aug 30th 2019
] - WOPRAI
[ Fri, Aug 30th 2019
] - WOPRAI
[ Fri, Aug 30th 2019
] - WOPRAI
[ Fri, Aug 30th 2019
] - WOPRAI
[ Fri, Aug 30th 2019
] - WOPRAI
[ Fri, Aug 30th 2019
] - WOPRAI
[ Fri, Aug 30th 2019
] - WOPRAI
[ Fri, Aug 30th 2019
] - WOPRAI
[ Fri, Aug 30th 2019
] - WOPRAI
[ Fri, Aug 30th 2019
] - WOPRAI
[ Fri, Aug 30th 2019
] - WOPRAI
[ Fri, Aug 30th 2019
] - WOPRAI
[ Fri, Aug 30th 2019
] - WOPRAI
Thu, August 29, 2019
[ Thu, Aug 29th 2019
] - WOPRAI
Christopher Raymond Initiated (BPMC) at Hold and Held Target at $85 on, Aug 29th, 2019
Christopher Raymond of Piper Sandler, Initiated "Blueprint Medicines Corporation" (BPMC) at Hold and Held Target at $85 on, Aug 29th, 2019.
Christopher has made no other calls on BPMC in the last 4 months.
There are 4 other peers that have a rating on BPMC. Out of the 4 peers that are also analyzing BPMC, 1 agrees with Christopher's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Dane Leone of "Raymond James" Initiated at Hold on, Thursday, August 15th, 2019
These are the ratings of the 3 analyists that currently disagree with Christopher
- Joel Beatty of "Baird" Initiated at Buy and Held Target at $120 on, Friday, July 19th, 2019
- Konstantinos Aprilakis of "Deutsche Bank" Initiated at Strong Buy and Held Target at $110 on, Thursday, July 18th, 2019
- Terence Flynn of "Goldman Sachs" Initiated at Strong Buy and Held Target at $125 on, Thursday, May 23rd, 2019
